Sign in
TerminatedNo phase

PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease

Key facts

Who runs it
NYU Langone Health
Where
New York, United StatesSee the site
Trial code
Status
Terminated
People taking part
32 people enrolled
Started
12 Jul 2021
Ended
31 Dec 2024
Type of study
Observational
Treatments tested
  • Coronary computed tomography angiography (CCTA)
  • Isovue
  • Nitroglycerin
  • Metoprolol
Record updated
29 April 2025
Why it stopped
Study was terminated due to funding expiration.

Who can take part

Age
18 years to 125 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Adult age ≥18 years referred for clinically indicated coronary angiography
  • Stable ischemic heart disease OR acute myocardial infarction as the indication for coronary angiography

Who cannot take part

  • History of allergic reaction to iodinated contrast media
  • Allergic reaction to iodinated contrast media
  • Clinical Exclusion criteria:
  • Estimated glomerular filtration rate < 45 mL/min
  • Pregnancy; Angiographic / Post-Cath Exclusion criteria:
  • Obstructive CAD (≥50% luminal obstruction in ≥1 major epicardial coronary arteries by invasive coronary angiography)

Where in United States

  • NYU Langone HealthNew York, United States

About the trial

What the trial wants to find out

Among patients with ischemic heart disease who are referred for coronary angiography, a substantial proportion have non-obstructive coronary artery disease (CAD). Myocardial infarction (MI) with non-obstructive coronary artery disease (MINOCA) accounts for 5-20% of patients with MI and preferentially affects women. MINOCA pathogenesis is varied and may include atherosclerotic plaque rupture, plaque erosion with thrombosis, vasospasm, embolization, dissection or a combination of mechanisms. Other patients may have clinically unrecognized myocarditis, or takotsubo syndrome masquerading as MI. Among patients referred for coronary angiography for the evaluation of stable ischemic heart disease, non-obstructive CAD is present in up to ~30% of men and ~60% of women. Stable ischemia with non-obstructive coronary arteries (INOCA) may be due to coronary microvascular dysfunction in up to 40% of these patients. Our understanding of mechanisms of MINOCA and INOCA remain incomplete. Coronary inflammation has been hypothesized as a potential mechanism contributing to coronary spasm in MINOCA and microvascular disease in INOCA.

The group in the trial

  • Intervention group

    Participants will be identified by review of the cardiac catheterization laboratory schedule each day by the principal investigator, a co-investigator, or a research coordinator. Participants with no obstructive CAD and completed microvascular testing will undergo a research CCTA.

    Treatment: Coronary computed tomography angiography (CCTA), Isovue, Nitroglycerin, and Metoprolol

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Single Center Study of Perivascular Coronary Inflammation in Patients With Myocardial Ischemia or Infarction With Non-Obstructive Coronary Arteries
Record updated
29 April 2025